These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

263 related items for PubMed ID: 34518481

  • 1. Effect of Enteral Vitamin A on Fecal Calprotectin in Extremely Preterm Infants: A Nested Prospective Observational Study.
    Rakshasbhuvankar AA, Pillow JJ, Patole SK, Nathan EA, Simmer K.
    Neonatology; 2021; 118(6):720-726. PubMed ID: 34518481
    [Abstract] [Full Text] [Related]

  • 2. Enteral Vitamin A for Reducing Severity of Bronchopulmonary Dysplasia: A Randomized Trial.
    Rakshasbhuvankar AA, Simmer K, Patole SK, Stoecklin B, Nathan EA, Clarke MW, Pillow JJ.
    Pediatrics; 2021 Jan; 147(1):. PubMed ID: 33386338
    [Abstract] [Full Text] [Related]

  • 3. Enteral vitamin A for reducing severity of bronchopulmonary dysplasia in extremely preterm infants: a randomised controlled trial.
    Rakshasbhuvankar A, Patole S, Simmer K, Pillow JJ.
    BMC Pediatr; 2017 Dec 16; 17(1):204. PubMed ID: 29246130
    [Abstract] [Full Text] [Related]

  • 4. Point-of-Care Fecal Calprotectin Monitoring in Preterm Infants at Risk for Necrotizing Enterocolitis.
    Nakayuenyongsuk W, Christofferson M, Stevenson DK, Sylvester K, Lee HC, Park KT.
    J Pediatr; 2018 May 16; 196():98-103.e1. PubMed ID: 29519542
    [Abstract] [Full Text] [Related]

  • 5. Early postnatal high-dose fat-soluble enteral vitamin A supplementation for moderate or severe bronchopulmonary dysplasia or death in extremely low birthweight infants (NeoVitaA): a multicentre, randomised, parallel-group, double-blind, placebo-controlled, investigator-initiated phase 3 trial.
    Meyer S, Bay J, Franz AR, Ehrhardt H, Klein L, Petzinger J, Binder C, Kirschenhofer S, Stein A, Hüning B, Heep A, Cloppenburg E, Muyimbwa J, Ott T, Sandkötter J, Teig N, Wiegand S, Schroth M, Kick A, Wurm D, Gebauer C, Linnemann K, Kittel J, Wieg C, Kiechl-Kohlendorfer U, Schmidt S, Böttger R, Thomas W, Brevis Nunez F, Stockmann A, Kriebel T, Müller A, Klotz D, Morhart P, Nohr D, Biesalski HK, Giannopoulou EZ, Hilt S, Poryo M, Wagenpfeil S, Haiden N, Ruckes C, Ehrlich A, Gortner L, NeoVitaA trial investigators.
    Lancet Respir Med; 2024 Jul 16; 12(7):544-555. PubMed ID: 38643780
    [Abstract] [Full Text] [Related]

  • 6. Fecal calprotectin levels are increased in infants with necrotizing enterocolitis.
    Aydemir O, Aydemir C, Sarikabadayi YU, Emre Canpolat F, Erdeve O, Biyikli Z, Dilmen U.
    J Matern Fetal Neonatal Med; 2012 Nov 16; 25(11):2237-41. PubMed ID: 22524488
    [Abstract] [Full Text] [Related]

  • 7. Oropharyngeal administration of mother's colostrum, health outcomes of premature infants: study protocol for a randomized controlled trial.
    Rodriguez NA, Vento M, Claud EC, Wang CE, Caplan MS.
    Trials; 2015 Oct 12; 16():453. PubMed ID: 26458907
    [Abstract] [Full Text] [Related]

  • 8. Effect of neutral and acidic oligosaccharides on fecal IL-8 and fecal calprotectin in preterm infants.
    Westerbeek EA, Mørch E, Lafeber HN, Fetter WP, Twisk JW, Van Elburg RM.
    Pediatr Res; 2011 Mar 12; 69(3):255-8. PubMed ID: 21228732
    [Abstract] [Full Text] [Related]

  • 9. Fecal calprotectin excretion in preterm infants during the neonatal period.
    Rougé C, Butel MJ, Piloquet H, Ferraris L, Legrand A, Vodovar M, Voyer M, de la Cochetière MF, Darmaun D, Rozé JC.
    PLoS One; 2010 Jun 11; 5(6):e11083. PubMed ID: 20552029
    [Abstract] [Full Text] [Related]

  • 10. The role of fecal calprotectin and lactoferrin in the diagnosis of necrotizing enterocolitis.
    Selimoğlu MA, Temel I, Yıldırım Ç, Özyaln F, Aktaş M, Karabiber H.
    Pediatr Crit Care Med; 2012 Jul 11; 13(4):452-4. PubMed ID: 22079952
    [Abstract] [Full Text] [Related]

  • 11. Early postnatal additional high-dose oral vitamin A supplementation versus placebo for 28 days for preventing bronchopulmonary dysplasia or death in extremely low birth weight infants.
    Meyer S, Gortner L, NeoVitaA Trial Investigators.
    Neonatology; 2014 Jul 11; 105(3):182-8. PubMed ID: 24434948
    [Abstract] [Full Text] [Related]

  • 12. Oral supplementation with probiotics in very-low-birth-weight preterm infants: a randomized, double-blind, placebo-controlled trial.
    Rougé C, Piloquet H, Butel MJ, Berger B, Rochat F, Ferraris L, Des Robert C, Legrand A, de la Cochetière MF, N'Guyen JM, Vodovar M, Voyer M, Darmaun D, Rozé JC.
    Am J Clin Nutr; 2009 Jun 11; 89(6):1828-35. PubMed ID: 19369375
    [Abstract] [Full Text] [Related]

  • 13. Fecal calprotectin in very low birth weight infants.
    Josefsson S, Bunn SK, Domellöf M.
    J Pediatr Gastroenterol Nutr; 2007 Apr 11; 44(4):407-13. PubMed ID: 17414135
    [Abstract] [Full Text] [Related]

  • 14. Serial fecal calprotectin in the prediction of necrotizing enterocolitis in preterm neonates.
    van Zoonen AGJF, Hulzebos CV, Muller Kobold AC, Kooi EMW, Bos AF, Hulscher JBF.
    J Pediatr Surg; 2019 Mar 11; 54(3):455-459. PubMed ID: 29859621
    [Abstract] [Full Text] [Related]

  • 15. Fecal calprotectin levels in preterm infants with and without feeding intolerance.
    Moussa R, Khashana A, Kamel N, Elsharqawy SE.
    J Pediatr (Rio J); 2016 Mar 11; 92(5):486-92. PubMed ID: 27317868
    [Abstract] [Full Text] [Related]

  • 16. Does Human Milk Fortifier Affect Intestinal Inflammation in Preterm Infants?
    Doshi H, Pandya S, Codipilly CN, Schanler RJ.
    Breastfeed Med; 2020 Dec 11; 15(12):776-778. PubMed ID: 32996776
    [Abstract] [Full Text] [Related]

  • 17. A randomized controlled trial protocol comparing the feeds of fresh versus frozen mother's own milk for preterm infants in the NICU.
    Sun H, Cao Y, Han S, Cheng R, Liu L, Liu J, Xia S, Zhang J, Li Z, Cheng X, Yang C, Pan X, Li L, Ding X, Wang R, Wu M, Li X, Shi L, Xu F, Yu F, Pan J, Zhang X, Li L, Yang J, Li M, Yan C, Zhou Q, Lu J, Wei M, Wang L, Yang L, Ye XY, Unger S, Kakulas F, Lee SK.
    Trials; 2020 Feb 11; 21(1):170. PubMed ID: 32046760
    [Abstract] [Full Text] [Related]

  • 18. Effect of early low-dose hydrocortisone on survival without bronchopulmonary dysplasia in extremely preterm infants (PREMILOC): a double-blind, placebo-controlled, multicentre, randomised trial.
    Baud O, Maury L, Lebail F, Ramful D, El Moussawi F, Nicaise C, Zupan-Simunek V, Coursol A, Beuchée A, Bolot P, Andrini P, Mohamed D, Alberti C, PREMILOC trial study group.
    Lancet; 2016 Apr 30; 387(10030):1827-36. PubMed ID: 26916176
    [Abstract] [Full Text] [Related]

  • 19. Enteral lactoferrin to prevent infection for very preterm infants: the ELFIN RCT.
    Griffiths J, Jenkins P, Vargova M, Bowler U, Juszczak E, King A, Linsell L, Murray D, Partlett C, Patel M, Berrington J, Embleton N, Dorling J, Heath PT, McGuire W, Oddie S.
    Health Technol Assess; 2018 Dec 30; 22(74):1-60. PubMed ID: 30574860
    [Abstract] [Full Text] [Related]

  • 20. Safety and Efficacy of Early Vitamin D Supplementation in Critically Ill Extremely Preterm Infants: An Ancillary Study of a Randomized Trial.
    Aristizabal N, Holder MP, Durham L, Ashraf AP, Taylor S, Salas AA.
    J Acad Nutr Diet; 2023 Jan 30; 123(1):87-94. PubMed ID: 35728797
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.